Two cases of incidental Podostroma cornu-damae poisoning

Article information

Abstract

INTRODUCTION

Only approximately 30 of the thousands of mushrooms worldwide are known to be fatally poisonous [1]. The most famous toxic mushroom is the genus Amanita, which contains the lethal toxin amatoxin [2]. However, there are few reports regarding other mushroom species.

Podostroma cornu-damae is a lethal mushroom belonging to the Hypocreaceae family. It contains a lethal toxin called trichothecene mycotoxin. As this mushroom resembles antler Ganoderma lucidum and Cordyceps in the early stage [3], amateur mushroom hunters have mistaken Podostroma cornu-damae for these mushrooms. This has resulted in fatal accidents (Figs. 1, 2).

Fig. 1.

Podostroma cornu-damae (Republished with credits to Taylor F. Lockwood, http://www.mushroom.pro).

Fig. 2.

Antler Ganoderma lucidum.

Many cases of accidental intoxication owing to this mushroom have been reported in Japan. In Korea, however, no cases were reported before 2013. Nevertheless, since then, cases of accidental intoxication of this mushroom have been reported. Here, we report two cases of poisoning by Podostroma cornu-damae.

CASE REPORT

Case 1

A 62-year-old woman, previously diagnosed with hypertension, was admitted to the emergency department due to desquamation of the hands and feet (Fig. 3) and alopecia (Fig. 4). The symptoms had started 7 days previously, and she tried taking oral medication and applying lotions prescribed by her dermatologist without improvement. The symptoms worsened, and she developed general weakness and mild nausea. Upon further questioning, she admitted that she had gathered wild mushrooms from a nearby mountain and had made tea from the mushrooms. She had been drinking 2 or 3 cups of mushroom tea for the previous 12 days.

Fig. 3.

Desquamation of the palms and fingers are present.

Fig. 4.

Alopecia is evident.

On admission, her blood pressure was 115/64 mmHg, heart rate was 97 beats/min, and temperature was 37.7°C. She complained of general weakness, fever, and light abdominal discomfort, and she had desquamation of the hands and feet and alopecia. There were no respiratory or gastrointestinal symptoms. Her physical examination showed no neurological deficits.

Blood tests showed severe bicytopenia with a white blood cell (WBC) count of 6,200/µL and an absolute neutrophil count <10, as well as a hemoglobin (Hb) level of 11.5 g/dL and platelet count of 29,000/µL. Electrolyte panels and biochemical laboratory measurements were carried out. The patient’s C-reactive protein (CRP) level was 21.18 mg/dL, which was elevated above the normal range. Other test results were within normal limits (blood urea nitrogen 33.8 mg/dL, creatinine 0.94 mg/dL, aspartate aminotransferase 7 IU/L, alanine aminotransferase 10 IU/L, creatine kinase-MB 0.51 ng/dL, and troponin T 0.019 ng/dL). A peripheral blood smear showed severe neutropenia, while a chest radiograph and electrocardiograms showed normal findings.

Although her history suggested mushroom intake to be the cause of her abnormal laboratory measurements, she was admitted and treated with prophylactic antibiotics and granulocyte colony-stimulating factor (G-CSF). We tested for Hantaan virus, tsutsugamushi, leptospirosis, and malaria antibody to rule out other infections, and two sets of blood cultures were performed immediately. All of the results were negative. A bone marrow biopsy showed hypocellular bone marrow.

Neutropenia persisted during her hospitalization, and on the third hospital day, her platelet count decreased to 10,000/µL. After 4 pints of platelet infusion and continuous G-CSF infusion, her blood cell count improved without any other infective, renal, or cardiovascular complications. On the thirteenth day of her hospitalization, the laboratory measurements showed a WBC count of 2,000/µL, absolute neutrophil count (ANC) of 710, segmented neutrophil count of 42%, Hb level of 7.9 g/dL, and platelet count of 144,000/µL. She was then discharged. One week later, at an outpatient follow-up visit, her blood cell count had recovered fully.

DISCUSSION

Podostroma cornu-damae is an ascomycete fungus and was originally described by Patouillard as Hypocrea cornu-damae (1895) and said to originate in Tibet. Podostroma cornu-damae was next described by Boedijn et al. (1934) and Doi et al. (1973). It was then published in Saccardo’s famous Sylloge Fungorum (1905) and was named since [4]. Many accidental poisonings by Podostroma cornu-damae can be attributed to its similarity to antler Ganoderma lucidum and Cordyceps (Figs. 1, 2). Podostroma cornu-damae is known to inhabit the Java Islands, Korea, Japan, and China [5,6].

In 1999, five people in Japan drank sake made from about 1 g of this toxic mushroom, resulting in a death 2 days later despite intensive treatment [5]. Another Japanese report documented 13 cases of ingestion, including 2 people who died [3]. In Korea, 4 people have reportedly been intoxicated by this mushroom, of whom 3 drank tea made from its fruit body. One died of multi-organ failure [7], and the 2 others were discharged from the hospital without complications [7,8]. One man was reported to have boiled the mushroom and eaten it. He developed nausea, vomiting, and fever within 3 hours of consumption. His lungs showed hemorrhagic and necrotic changes, and he died within 12 days due to multi-organ failure [9].

The case reported by Ahn et al. [7], is similar to ours in many ways. The patient consumed the mushroom in tea form and showed similar symptoms such as fever, generalized weakness, alopecia, and desquamation of the palms and soles (as in case 1). Both were treated with prophylactic antibiotics, G-CSF, and platelet transfusion. Our patient recovered gradually, while the patient described by Ahn et al. [7], despite being intubated and treated with continuous renal replacement, experienced worsening bilateral lower lung field consolidation and died due to multi-organ failure.

The most common complaints were abdominal pain, desquamation of the hands and feet, alopecia, perception changes, and speech impediment. Further evaluation showed blood cell count anomalies, such as pancytopenia or bicytopenia, and cerebellar atrophy. Autopsies showed that the patients died of multi-organ failure, including disseminated intravascular coagulation, kidney failure, and hepatic failure [10]. These symptoms were similar to animals dosed with trichothecene mycotoxin. In Japan, researchers have identified macrocyclic trichothecene toxins, such as satratoxin H, satratoxin H 12’, 13’-diacetate, satratoxin H 12’-acetate, and satratoxin H 13’-acetate. The mice died the next day after they were injected with 0.5 g of the toxin [5].

No specific treatment has been found for poisoning with this lethal mushroom, but one patient who showed severe hemophagocytosis and bicytopenia was treated with abundant intravenous fluids (12 liters over 9 hours), plasmapheresis, and G-CSF. He recovered fully after over 1 month of intensive treatment [6]. Other patients, like ours, were treated using G-CSF and prophylactic antibiotics and recovered without complications.

The onset of symptoms depends on the amount and manner of oral intake. Cases in which a person drank or ate the fruit body itself resulted in intake of large amounts of the toxin, thereby leading to symptoms within only a few hours or few days. When patients make tea and drink small amounts of the mushroom over a long period, it takes 2 to 4 weeks for symptoms to appear.

In the current case, the patients complained of alopecia and desquamation of the hands, with no other symptoms. It took 2 weeks for these symptoms to develop. Both were treated with G-CSF, and their symptoms and abnormal laboratory measurements remitted without any complications. The mechanism by which alopecia and desquamation appears has not yet been discovered.

We hope these cases will help treat future patients who present with an unknown cause of neutropenic fever and pancytopenia as well as desquamation on their palms and soles. Furthermore, as the number of cases of Podostroma cornu-damae poisoning is increasing, physicians should be sure to ask patients about any history of ingesting wild mushrooms when such symptoms appear.

Article information Continued

Notes